PART I Overview We are a technology-enabled research organization engaged in creating technology solutions to be utilized in drug discovery and development. Our research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. Our pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. At the core of our research pl...
Q2 FY2026 — expected 2026-09-17
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-07-23 | 2025-04-30 | 0001628280-25-035765 | EDGAR | 29K words |
| 2024-07-19 | 2024-04-30 | 0001628280-24-032321 | EDGAR | — |
| 2023-07-24 | 2023-04-30 | 0001628280-23-025464 | EDGAR | — |
| 2022-07-22 | 2022-04-30 | 0001628280-22-019309 | EDGAR | — |
| 2021-07-26 | 2021-04-30 | 0001628280-21-014464 | EDGAR | — |
| 2020-07-28 | 2020-04-30 | 0001628280-20-010734 | EDGAR | — |
| 2019-07-29 | 2019-04-30 | 0001628280-19-009139 | EDGAR | — |
| 2018-07-30 | 2018-04-30 | 0001628280-18-009773 | EDGAR | — |
| 2017-07-28 | 2017-04-30 | 0001628280-17-007429 | EDGAR | — |
| 2016-07-29 | 2016-04-30 | 0001628280-16-017936 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2026-01-31 | 0001628280-26-017345 | EDGAR | 14K words |
| 2025-12-15 | 2025-10-31 | 0001628280-25-057082 | EDGAR | — |
| 2025-09-15 | 2025-07-31 | 0000771856-25-000023 | EDGAR | — |
| 2025-03-17 | 2025-01-31 | 0001628280-25-012941 | EDGAR | — |
| 2024-12-16 | 2024-10-31 | 0001628280-24-051389 | EDGAR | — |
| 2024-09-13 | 2024-07-31 | 0001628280-24-040312 | EDGAR | — |
| 2024-03-15 | 2024-01-31 | 0001628280-24-011279 | EDGAR | — |
| 2023-12-13 | 2023-10-31 | 0001628280-23-041457 | EDGAR | — |
| 2023-09-13 | 2023-07-31 | 0001628280-23-032212 | EDGAR | — |
| 2023-03-16 | 2023-01-31 | 0001628280-23-008251 | EDGAR | — |
| 2022-12-13 | 2022-10-31 | 0001628280-22-031818 | EDGAR | — |
| 2022-09-12 | 2022-07-31 | 0001628280-22-024751 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-30 | 0001628280-26-021941 | EDGAR | 1K words |
| 2026-03-12 | 0001628280-26-017259 | EDGAR | — |
| 2025-12-15 | 0001628280-25-057020 | EDGAR | — |
| 2025-10-16 | 0001628280-25-045241 | EDGAR | — |
| 2025-09-15 | 0000771856-25-000022 | EDGAR | — |
| 2025-07-23 | 0001628280-25-035727 | EDGAR | — |
| 2025-07-21 | 0001628280-25-035424 | EDGAR | — |
| 2025-03-11 | 0001628280-25-012022 | EDGAR | — |
| 2024-12-11 | 0001628280-24-050789 | EDGAR | — |
| 2024-10-15 | 0001628280-24-042780 | EDGAR | — |
254 total filings indexed. 222 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000771856 |
| Ticker | CSBR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.championsoncology.com |
| Listed | 1994-10-31 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report